Surveys of NPAs
EPA SURVEY ON DIGITILISATION (2022)
Digital technology might offer psychiatry the potential for radical change in terms of service delivery and the development of new treatments. However, it also carries the risk of commercialised, unproven treatments entering the medical marketplace with detrimental effect.
In 2022, a Task Force group working under the umbrella of the Council of NPAs prepared a questionnaire gathering information on Digitalisation in European Psychiatry. The questionnaire was shared with the representatives of the EPA National Psychiatric Associations (NPAs) members. Out of the 44 invited countries, responses from 35 countries were received.